To determine predictors of treatment-refractory fever and the relation between refractory fever and clinical outcome in patients with aneurysmal subarachnoid hemorrhage (SAH), researchers analyzed data from 353 patients with SAH culled from a single-center, prospective database of consecutive SAH patients.